CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Conversion Director acquired 80,000 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 10,000 shares (conversion)
- 4 Conversion Director acquired 1,500,000 shares (conversion)
- 4 Conversion 10% owner acquired 1,500,000 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,400 shares at $0.94 ($9,825)
- 4 Open-market buy CEO, Pres., CFO, Treas & Secty bought 5,200 shares at $0.97 ($5,044)
- 4 Open-market buy CEO, Pres., CFO, Treas & Secty bought 12,000 shares at an average $0.91 ($10,955)
- 4 Gift CEO, Pres., CFO Treas & Secty gave 20,000 shares (gift)
- 3/A Insider 3/A
- 4/A Derivatives Options or other derivatives
Page 3 of 4 · 80 filings